TY - JOUR AU - Zhang, L. AU - Conejo-Garcia, J. R. AU - Katsaros, D. AU - Gimotty, P. A. AU - Massobrio, M. AU - Regnani, G. PY - 2003 DA - 2003// TI - Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer JO - N Engl J Med VL - 348 UR - https://doi.org/10.1056/NEJMoa020177 DO - 10.1056/NEJMoa020177 ID - Zhang2003 ER - TY - JOUR AU - Sato, E. AU - Olson, S. H. AU - Ahn, J. AU - Bundy, B. AU - Nishikawa, H. AU - Qian, F. PY - 2005 DA - 2005// TI - Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer JO - Proc Natl Acad Sci U S A VL - 102 UR - https://doi.org/10.1073/pnas.0509182102 DO - 10.1073/pnas.0509182102 ID - Sato2005 ER - TY - JOUR AU - Adams, S. F. AU - Levine, D. A. AU - Cadungog, M. G. AU - Hammond, R. AU - Facciabene, A. AU - Olvera, N. PY - 2009 DA - 2009// TI - Intraepithelial T cells and tumor proliferation: impact on the benefit from surgical cytoreduction in advanced serous ovarian cancer JO - Cancer VL - 115 UR - https://doi.org/10.1002/cncr.24317 DO - 10.1002/cncr.24317 ID - Adams2009 ER - TY - JOUR AU - Clarke, B. AU - Tinker, A. V. AU - Lee, C. H. AU - Subramanian, S. AU - Rijn, M. AU - Turbin, D. PY - 2009 DA - 2009// TI - Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss JO - Mod Pathol VL - 22 UR - https://doi.org/10.1038/modpathol.2008.191 DO - 10.1038/modpathol.2008.191 ID - Clarke2009 ER - TY - JOUR AU - Hamanishi, J. AU - Mandai, M. AU - Iwasaki, M. AU - Okazaki, T. AU - Tanaka, Y. AU - Yamaguchi, K. PY - 2007 DA - 2007// TI - Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer JO - Proc Natl Acad Sci U S A VL - 104 UR - https://doi.org/10.1073/pnas.0611533104 DO - 10.1073/pnas.0611533104 ID - Hamanishi2007 ER - TY - JOUR AU - Shah, C. A. AU - Allison, K. H. AU - Garcia, R. L. AU - Gray, H. J. AU - Goff, B. A. AU - Swisher, E. M. PY - 2008 DA - 2008// TI - Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer JO - Gynecol Oncol VL - 109 UR - https://doi.org/10.1016/j.ygyno.2008.01.010 DO - 10.1016/j.ygyno.2008.01.010 ID - Shah2008 ER - TY - JOUR AU - Nielsen, J. S. AU - Sahota, R. A. AU - Milne, K. AU - Kost, S. E. AU - Nesslinger, N. J. AU - Watson, P. H. PY - 2012 DA - 2012// TI - CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-12-0234 DO - 10.1158/1078-0432.CCR-12-0234 ID - Nielsen2012 ER - TY - JOUR AU - Curiel, T. J. AU - Coukos, G. AU - Zou, L. AU - Alvarez, X. AU - Cheng, P. AU - Mottram, P. PY - 2004 DA - 2004// TI - Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival JO - Nat Med VL - 10 UR - https://doi.org/10.1038/nm1093 DO - 10.1038/nm1093 ID - Curiel2004 ER - TY - JOUR AU - Winter, W. E. AU - Maxwell, G. L. AU - Tian, C. AU - Sundborg, M. J. AU - Rose, G. S. AU - Rose, P. G. PY - 2008 DA - 2008// TI - Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.13.1953 DO - 10.1200/JCO.2007.13.1953 ID - Winter2008 ER - TY - JOUR AU - Kullander, S. AU - Rausing, A. AU - Trope, C. PY - 1978 DA - 1978// TI - Human ovarian tumours heterotransplanted to "nude" mice JO - Acta Obstet Gynecol Scand VL - 57 UR - https://doi.org/10.3109/00016347809155895 DO - 10.3109/00016347809155895 ID - Kullander1978 ER - TY - JOUR AU - Yokota, S. J. AU - Facciponte, J. G. AU - Kelleher, R. J. AU - Shultz, L. D. AU - Loyall, J. L. AU - Parsons, R. R. PY - 2013 DA - 2013// TI - Changes in ovarian tumor cell number, tumor vasculature, and T cell function monitored in vivo using a novel xenograft model JO - Cancer Immun VL - 13 ID - Yokota2013 ER - TY - JOUR AU - Bankert, R. B. AU - Balu-Iyer, S. V. AU - Odunsi, K. AU - Shultz, L. D. AU - Kelleher, R. J. AU - Barnas, J. L. PY - 2011 DA - 2011// TI - Humanized mouse model of ovarian cancer recapitulates patient solid tumor progression, ascites formation, and metastasis JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0024420 DO - 10.1371/journal.pone.0024420 ID - Bankert2011 ER - TY - JOUR AU - Geller, M. A. AU - Knorr, D. A. AU - Hermanson, D. A. AU - Pribyl, L. AU - Bendzick, L. AU - McCullar, V. PY - 2013 DA - 2013// TI - Intraperitoneal delivery of human natural killer cells for treatment of ovarian cancer in a mouse xenograft model JO - Cytotherapy VL - 15 UR - https://doi.org/10.1016/j.jcyt.2013.05.022 DO - 10.1016/j.jcyt.2013.05.022 ID - Geller2013 ER - TY - JOUR AU - Dinulescu, D. M. AU - Ince, T. A. AU - Quade, B. J. AU - Shafer, S. A. AU - Crowley, D. AU - Jacks, T. PY - 2005 DA - 2005// TI - Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer JO - Nat Med VL - 11 UR - https://doi.org/10.1038/nm1173 DO - 10.1038/nm1173 ID - Dinulescu2005 ER - TY - JOUR AU - Orsulic, S. AU - Li, Y. AU - Soslow, R. A. AU - Vitale-Cross, L. A. AU - Gutkind, J. S. AU - Varmus, H. E. PY - 2002 DA - 2002// TI - Induction of ovarian cancer by defined multiple genetic changes in a mouse model system JO - Cancer Cell VL - 1 UR - https://doi.org/10.1016/S1535-6108(01)00002-2 DO - 10.1016/S1535-6108(01)00002-2 ID - Orsulic2002 ER - TY - JOUR AU - Kim, J. AU - Coffey, D. M. AU - Creighton, C. J. AU - Yu, Z. AU - Hawkins, S. M. AU - Matzuk, M. M. PY - 2012 DA - 2012// TI - High-grade serous ovarian cancer arises from fallopian tube in a mouse model JO - Proc Natl Acad Sci U S A VL - 109 UR - https://doi.org/10.1073/pnas.1117135109 DO - 10.1073/pnas.1117135109 ID - Kim2012 ER - TY - JOUR AU - Connolly, D. C. AU - Bao, R. AU - Nikitin, A. Y. AU - Stephens, K. C. AU - Poole, T. W. AU - Hua, X. PY - 2003 DA - 2003// TI - Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer JO - Cancer Res VL - 63 ID - Connolly2003 ER - TY - JOUR AU - El-Naggar, S. M. AU - Malik, M. T. AU - Martin, A. AU - Moore, J. P. AU - Proctor, M. AU - Hamid, T. PY - 2007 DA - 2007// TI - Development of cystic glandular hyperplasia of the endometrium in Mullerian inhibitory substance type II receptor-pituitary tumor transforming gene transgenic mice JO - J Endocrinol VL - 194 UR - https://doi.org/10.1677/JOE-06-0036 DO - 10.1677/JOE-06-0036 ID - El-Naggar2007 ER - TY - JOUR AU - Liang, S. AU - Yang, N. AU - Pan, Y. AU - Deng, S. AU - Lin, X. AU - Yang, X. PY - 2009 DA - 2009// TI - Expression of activated PIK3CA in ovarian surface epithelium results in hyperplasia but not tumor formation JO - PLoS One VL - 4 UR - https://doi.org/10.1371/journal.pone.0004295 DO - 10.1371/journal.pone.0004295 ID - Liang2009 ER - TY - JOUR AU - Roberts, P. C. AU - Mottillo, E. P. AU - Baxa, A. C. AU - Heng, H. H. AU - Doyon-Reale, N. AU - Gregoire, L. PY - 2005 DA - 2005// TI - Sequential molecular and cellular events during neoplastic progression: a mouse syngeneic ovarian cancer model JO - Neoplasia VL - 7 UR - https://doi.org/10.1593/neo.05358 DO - 10.1593/neo.05358 ID - Roberts2005 ER - TY - STD TI - Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474(7353):609–15. doi:10.1038/nature10166. Erratum in: Nature. 2012 Oct 11;490(7419):298. PubMed PMID: 21720365; PubMed Central PMCID: PMC3163504. ID - ref21 ER - TY - JOUR AU - Jacobs, A. J. AU - Curtis, G. L. AU - Newland, J. R. AU - Wilson, R. B. AU - Ryan, W. L. PY - 1984 DA - 1984// TI - Chemical induction of ovarian epithelial carcinoma in mice JO - Gynecol Oncol VL - 18 UR - https://doi.org/10.1016/0090-8258(84)90025-8 DO - 10.1016/0090-8258(84)90025-8 ID - Jacobs1984 ER - TY - JOUR AU - Nishida, T. AU - Sugiyama, T. AU - Kataoka, A. AU - Ushijima, K. AU - Yakushiji, M. PY - 1998 DA - 1998// TI - Histologic characterization of rat ovarian carcinoma induced by intraovarian insertion of a 7,12-dimethylbenz[a]anthracene-coated suture: common epithelial tumors of the ovary in rats? JO - Cancer VL - 83 UR - https://doi.org/3.0.CO;2-S DO - 3.0.CO;2-S ID - Nishida1998 ER - TY - JOUR AU - Roby, K. F. AU - Taylor, C. C. AU - Sweetwood, J. P. AU - Cheng, Y. AU - Pace, J. L. AU - Tawfik, O. PY - 2000 DA - 2000// TI - Development of a syngeneic mouse model for events related to ovarian cancer JO - Carcinogenesis VL - 21 UR - https://doi.org/10.1093/carcin/21.4.585 DO - 10.1093/carcin/21.4.585 ID - Roby2000 ER - TY - JOUR AU - Hung, C. F. AU - Tsai, Y. C. AU - He, L. AU - Wu, T. C. PY - 2007 DA - 2007// TI - Control of mesothelin-expressing ovarian cancer using adoptive transfer of mesothelin peptide-specific CD8+ T cells JO - Gene Ther VL - 14 UR - https://doi.org/10.1038/sj.gt.3302913 DO - 10.1038/sj.gt.3302913 ID - Hung2007 ER - TY - JOUR AU - Toyoshima, M. AU - Tanaka, Y. AU - Matumoto, M. AU - Yamazaki, M. AU - Nagase, S. AU - Sugamura, K. PY - 2009 DA - 2009// TI - Generation of a syngeneic mouse model to study the intraperitoneal dissemination of ovarian cancer with in vivo luciferase imaging JO - Luminescence VL - 24 UR - https://doi.org/10.1002/bio.1112 DO - 10.1002/bio.1112 ID - Toyoshima2009 ER - TY - JOUR AU - Li, C. AU - Chacko, A. M. AU - Hu, J. AU - Hasegawa, K. AU - Swails, J. AU - Grasso, L. PY - 2014 DA - 2014// TI - Antibody-based tumor vascular theranostics targeting endosialin/TEM1 in a new mouse tumor vascular model JO - Cancer Biol Ther VL - 15 UR - https://doi.org/10.4161/cbt.27825 DO - 10.4161/cbt.27825 ID - Li2014 ER - TY - JOUR AU - Rabinovich, B. A. AU - Ye, Y. AU - Etto, T. AU - Chen, J. Q. AU - Levitsky, H. I. AU - Overwijk, W. W. PY - 2008 DA - 2008// TI - Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer JO - Proc Natl Acad Sci U S A VL - 105 UR - https://doi.org/10.1073/pnas.0804105105 DO - 10.1073/pnas.0804105105 ID - Rabinovich2008 ER - TY - JOUR AU - Neff, B. A. AU - Voss, S. G. AU - Allen, C. AU - Schroeder, M. A. AU - Driscoll, C. L. AU - Link, M. J. PY - 2009 DA - 2009// TI - Bioluminescent imaging of intracranial vestibular schwannoma xenografts in NOD/SCID mice JO - Otol Neurotol VL - 30 UR - https://doi.org/10.1097/MAO.0b013e31818b6cea DO - 10.1097/MAO.0b013e31818b6cea ID - Neff2009 ER - TY - JOUR AU - Goodell, V. AU - McNeel, D. AU - Disis, M. L. PY - 2008 DA - 2008// TI - His-tag ELISA for the detection of humoral tumor-specific immunity JO - BMC Immunol VL - 9 UR - https://doi.org/10.1186/1471-2172-9-23 DO - 10.1186/1471-2172-9-23 ID - Goodell2008 ER - TY - JOUR AU - Lu, H. AU - Knutson, K. L. AU - Gad, E. AU - Disis, M. L. PY - 2006 DA - 2006// TI - The tumor antigen repertoire identified in tumor-bearing neu transgenic mice predicts human tumor antigens JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-06-1083 DO - 10.1158/0008-5472.CAN-06-1083 ID - Lu2006 ER - TY - JOUR AU - Park, K. H. AU - Gad, E. AU - Goodell, V. AU - Dang, Y. AU - Wild, T. AU - Higgins, D. PY - 2008 DA - 2008// TI - Insulin-like growth factor-binding protein-2 is a target for the immunomodulation of breast cancer JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-07-5891 DO - 10.1158/0008-5472.CAN-07-5891 ID - Park2008 ER - TY - JOUR AU - Dang, Y. AU - Wagner, W. M. AU - Gad, E. AU - Rastetter, L. AU - Berger, C. M. AU - Holt, G. E. PY - 2012 DA - 2012// TI - Dendritic cell-activating vaccine adjuvants differ in the ability to elicit antitumor immunity due to an adjuvant-specific induction of immunosuppressive cells JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-12-0113 DO - 10.1158/1078-0432.CCR-12-0113 ID - Dang2012 ER - TY - JOUR AU - Goodell, V. AU - Salazar, L. G. AU - Urban, N. AU - Drescher, C. W. AU - Gray, H. AU - Swensen, R. E. PY - 2006 DA - 2006// TI - Antibody immunity to the p53 oncogenic protein is a prognostic indicator in ovarian cancer JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.03.2813 DO - 10.1200/JCO.2005.03.2813 ID - Goodell2006 ER - TY - JOUR AU - Hamanishi, J. AU - Mandai, M. AU - Iwasaki, M. AU - Okazaki, T. AU - Tanaka, Y. AU - Yamaguchi, K. PY - 2007 DA - 2007// TI - Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer JO - Proc Natl Acad Sci U S A VL - 104 UR - https://doi.org/10.1073/pnas.0611533104 DO - 10.1073/pnas.0611533104 ID - Hamanishi2007 ER - TY - JOUR AU - Milne, K. AU - Barnes, R. O. AU - Girardin, A. AU - Mawer, M. A. AU - Nesslinger, N. J. AU - Ng, A. PY - 2008 DA - 2008// TI - Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer JO - PLoS One VL - 3 UR - https://doi.org/10.1371/journal.pone.0003409 DO - 10.1371/journal.pone.0003409 ID - Milne2008 ER - TY - JOUR AU - Goto, H. AU - Yang, B. AU - Petersen, D. AU - Pepper, K. A. AU - Alfaro, P. A. AU - Kohn, D. B. PY - 2003 DA - 2003// TI - Transduction of green fluorescent protein increased oxidative stress and enhanced sensitivity to cytotoxic drugs in neuroblastoma cell lines JO - Mol Cancer Ther VL - 2 ID - Goto2003 ER - TY - JOUR AU - Liu, H. S. AU - Jan, M. S. AU - Chou, C. K. AU - Chen, P. H. AU - Ke, N. J. PY - 1999 DA - 1999// TI - Is green fluorescent protein toxic to the living cells? JO - Biochem Biophys Res Commun VL - 260 UR - https://doi.org/10.1006/bbrc.1999.0954 DO - 10.1006/bbrc.1999.0954 ID - Liu1999 ER - TY - JOUR AU - Petkov, S. P. AU - Heuts, F. AU - Krotova, O. A. AU - Kilpelainen, A. AU - Engstrom, G. AU - Starodubova, E. S. PY - 2013 DA - 2013// TI - Evaluation of immunogen delivery by DNA immunization using non-invasive bioluminescence imaging JO - Hum Vaccin Immunother VL - 9 UR - https://doi.org/10.4161/hv.25561 DO - 10.4161/hv.25561 ID - Petkov2013 ER - TY - JOUR AU - Duraiswamy, J. AU - Freeman, G. J. AU - Coukos, G. PY - 2013 DA - 2013// TI - Therapeutic PD-1 pathway blockade augments with other modalities of immunotherapy T-cell function to prevent immune decline in ovarian cancer JO - Cancer Res VL - 73 UR - https://doi.org/10.1158/0008-5472.CAN-13-1550 DO - 10.1158/0008-5472.CAN-13-1550 ID - Duraiswamy2013 ER -